Abstract
Generally antimicrobials for treatment of pneumonia are chosen to target the usual bacterial etiological agents. Such regimens are unable to cure patients of pneumonia caused by ‘unusual organisms’ mycoplasma, chlamydia,Pneumocystis carinii andLegionella pneumophilus). Thus, there is a need to anticipate their presence in appropriate cases and to plan the initial antimicrobial therapy accordingly. Studies in Europe as well as India have shown that such infections form a fairly substantial percentage of community acquired pneumonia in children.Mycoplasma pneumonias and Chlamydia pneumoniae are common in school age children whileChlamydia trachomatis occurs in early infancy.Pneumocystis carinii is an important pathogen in immunocompromised children. Routine laboratory tests and radiological features are not specific enough to give accurate diagnosis of these infections for which one has to depend on sophisticated culture techniques, immunological tests for the antigens or antibodies and polymerase chain reaction. Mycoplasma, chlamydia and legionella infections respond to macrolide antibiotics and for pneumocystis infections, trimethoprim-sulfamethaxozole or pentamidine is the drug of choice. Overall prognosis with appropriate treatment is good except forP. carinii infection in immunocompromised host which carries a high mortality and recurrence rate.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kosma TH, Korppi M, Jokinen Cet al. Etiology of childhood pneumonia. Serologic results of a prospective, population based study.Pediatr Infect Dis J 1998; 17: 986–91.
Wars ME, Toikka P, Saarinen Tet al. Diagnosis ofMycoplasma pneumoniae pneumonia in children.J Clin Microbiol 1998; 36: 3155–9.
Ramamoorthi U, Rao UA, Thyagarajan SPet al. Mycoplasma pneumoniae in lower respiratory tract infections.Indian J Med Microbiol 1996; 14: 209–212.
Nadar S, Joque S, Brahmadattan KN, Mathai D. A hospital based study of community acquired mycoplasma and legionella lower respiratory tract infections in southern India.Indian Pract 1997; 50: 481–486.
Rastawicki W, Kaluzewski S, Jagielski M. Occurrence of serologically verifiedMycoplasma pneumoniae infections in Poland in 1970 in 1970–1995.Eut J Epidemiol 1998; 14:37–40.
Shulman ST, Barlett J, Clyde WAet al. The unusual severity of mycoplasmal pneumonia in children with sickle cell disease.N Engl J Med 1972; 287:164.
Orliech SI, Walker MS, Kuhls TI. Severe mycoplasma pneumonia in young children with Down syndrome.Clin Pediatr 1992; 31:409.
Baum SG, Mandell GL, Bannet JE and Dolin R (eds).Mycoplasma pneumoniae and atypical pneumonia. In:Principles and Practice of Infectious Disease. Churchill Livnigstone (New York) 1995; 1704–1713.
Fernald GW, Chernick V, Boat TF (eds). Infections of the respiratory tract due toMycoplasma pneumoniae. In:Kendig’s Disorders of the Respiratory Tract in Children. WB Saunders Co (Philadelphia). 1998; 526–532.
Uldum SA, Jensen JS, Sondergard-Anderson Jet al. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies toMycoplasma pneumoniae.J Clin Microbiol 1992; 30:1198.
Cimolai N, Cheong ACH. IgM anti-Pi immunoblotting. A standard for the rapid serologic diagnosis ofMycoplasma pneumoniae infection in pediatric care.Chest 1992; 102:477.
Matas L, Dominguez J, DeOry Fet al. Evaluation of Merdian ImmunoCard Mycoplasma test for the detection ofMycoplasma pneumoniae specific IgM in pediatric patients.Scand J Infect Dis 1998; 30: 289–93.
Kok T-W, Varkanis G, Marmion BPet al. Laboratory diagnosis ofMycoplasma pneumoniae infection. 1. Direct detection of antigen in respiratory exudates by enzyme immunoassay.Epidemiol Infect 1988; 101: 669.
Harris R, Marmion BP, Varkanis Get al. Laboratory diagnosis ofMycoplasma pneumoniae infection 2. Comparison of methods for the direct detection of specific antigen or nucleic acid sequences in respiratory exudates.Epidemiol Infect. 1988; 101: 685.
Dular R, Kajioka R, Kasatiya S. Comparison of Gen Probe commercial kit and culture technique for the diagnosis ofMycoplasma pneumoniae infection.J Clin Microbiol 1988; 26:1068.
Abele-Horn M, Busch U, Nitschko Het al. Molecular approaches to diagnosis of pulmonary diseases due toMycoplasma pneumoniae.J Clin Microbiol 1998; 36: 548–51.
Sasaki T, Kenri T, Okazaki Net al. Epidemiological study ofMycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene.J Clin Microbiol 1996; 34:447–449.
Schachter J, Grossman M, Sweet RLet al. Prospective study of perinatal transmission ofChlamydia trachomatis.JAMA 1986; 255:334–337.
Schachter J, Grossman M, Remington JS, Klein JO (eds). In:Infectious Diseases of the Fetus and Newborn Infant. WB Saunders Co (Philadlephia). 1995; 567–667.
Tipple MA, Beem MO, Saxon EMet al. Clilnical characteristics of the afebrile pneumonia associated withChlamydia trachomatis infection in infants less than six months of age.Pediatrics 1979; 63: 192–197.
Brasfield DM, Stagno S, Whitley RJet al. Infants pneumonitis associated with cytomegalovirus. chlamydia, pneumocysetis, and ureaplasma: Following up.Pediatrics 1987; 79 : 76–83.
Weiss SG, Newcomb RW, Beem MO. Pulmonary assessment of children after chlamydial pneumonia of infants.J Pediatr 1986; 108: 659–664.
Wang SP and Grayston JT. Immunological relationship between genital TRIC, lymphogranuloma venerum and related organisms in a new microtiter indirect immunofluroescence test.Am J Ophthalmol 1970; 70:367–374.
Wang SP, Grayston JT, Alexander ERet al. Simplified microimmunofluorescence test with trachoma — lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody.J Clin Microbiol 1975; 1:250–255.
Grayston JH, Mandell GL, Bannet GL and Doli R (eds).Chlamydia pneumoniae (TWAR). In:Principles and Practice of Infectious Diseases. Churchill Livingstone (New York) 1995; 1704–1713.
Saikky P, Rutu P, Leinonen Met al. Acute lower respiratory tract infections associated with chlamydial TWAR antibody in Filipino children.J Infect Dis 1988; 158; 1095–1097.
Block S, Hendrick J, Hammerschlag MRitet al.Mycoplasma pneumoniae andChlamydia pneumoniae in pediatric community acquired pneumonia: comparative efficacy and safety of clarithromycin ethylsuccinate.J Pediatr Infect Dis 1995; 14:471.
Hahn DI, Dodge RW, Colybjatnikov R. Association ofChlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult onset asthma.JAMA 1991; 266: 255–330.
Entire U, Roblin PM, Gelling Met al. The association ofChlamydia pneumoniae infection and reactive airway disease in children.Arch Pediatr Adolesc Med 1994; 148: 727.
Campbell LA, Perez-Melgosa M, Hamilton DJet al. Detection ofChlamydia pneumoniae by polymerase chain reaction.J Clin Microbiol 1992; 30:434–9.
Gaydos CA, Quinn TC, Eiden JJ. Identification ofChlamydia pneumoniae by DNA amplification of the 16Sr RNA gene.J Clin Microbiol 1992; 30:796–800.
Ramnirez JA, Ahkee S, Tolentino A, Miller RD, Summersgill JT. Diagnosis ofLegionella pneumophila, Mycoplasma pneumoniae, orChlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen.Diagnostic Microbiology and Infectious Disease 1996; 24:7–14.
Horie H, Kawakami H, Minoshima Ket al. Neonatal legionnaires disease. Histopathological finding in an autopsied neonate.Acta Pathol Jpn 1992; 42:427–31.
Holmberg RE, Pavia AT, Montgomery Det al. NosocomialLegionella pneumonia in the neonate.Pediatrics 1993:92:450–3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chugh, K. Pneumonia due to unusual organisms in children. Indian J Pediatr 66, 929–936 (1999). https://doi.org/10.1007/BF02723871
Issue Date:
DOI: https://doi.org/10.1007/BF02723871